Andrew Reisner Receives Chair of CHOA Neurotrauma

    A.Reisner

    Andrew Reisner, MD, an Assistant Professor with the Department of Neurosurgery and Pediatric Neurosurgeron with Children’s Healthcare of Atlanta (CHOA), received the newly named Chair for Neurotrauma at CHOA for his significant work improving outcomes for patients with traumatic brain injuries.  The $2 million chair, given by Elaine and John Carlos, will support research to help advance care for traumatic brain injuries and concussion-related issues.  

    Dr. Reisner was instrumental in the development of the Traumatic Brain Injury and Concussion programs at CHOA. Clinical successes include a 40 percent increase in survival among children with severe traumatic brain injury and improved quality in concussion care in the community, as recently published in the Journal of Pediatrics. Research by these teams has led to nearly 20 peer-reviewed publications and more than 40 presentations in the last few years alone. In addition, Dr. Reisner is the namesake of the Andrew Reisner, MD Traumatic Brain Injury Fund established by patient families.

    Daniel Barrow, MD, Pamela Rollins Professor and Chairman of the Department of Neurosurgery, is proud to see his long-time colleague receive this honor with CHOA.

    “This is a much-deserved honor bestowed on Dr. Reisner,” Barrow said.   “I have known him well since he was a resident in neurosurgery training here at Emory with us in the 1980s and from my first encounter found him to be committed to excellence.  During his career as a pediatric neurosurgeon, he has been a valuable asset as a faculty member of our Department of Neurosurgery and leader at Children’s Healthcare of Atlanta.  He has an unwavering commitment to providing the highest level of care to his patients, as well as passing along his knowledge to the next generation of neurosurgeons.”

    The Carlos’ gift of the Chair for Neurotrauma not only honors Dr. Reisner, but also helps ensure traumatic brain injury research at CHOA will continue into the future.  Dr. Reisner’s research priority will be identifying hematologic disturbances associated with traumatic brain injury, and identifying a reliable biomarker for traumatic brain injury. Biomarkers are measurable, scientific indicators that can help providers recognize and assess patients’ conditions. Currently, no biomarker exists for traumatic brain injury. To work toward this goal, the team is collaborating with Emory University’s Chia-Yi Kuan, MD, PhD, who conducts research through the Children’s Center for Neurosciences Research.